132 related articles for article (PubMed ID: 36316970)
1. Ethical Frameworks for Disclosure of Alzheimer Disease Biomarkers to Research Participants: Conflicting Norms and a Nuanced Policy.
Bunnik EM; Smedinga M; Milne R; Georges J; Richard E; Schermer MHN
Ethics Hum Res; 2022 Nov; 44(6):2-13. PubMed ID: 36316970
[TBL] [Abstract][Full Text] [Related]
2. On the personal utility of Alzheimer's disease-related biomarker testing in the research context.
Bunnik EM; Richard E; Milne R; Schermer MHN
J Med Ethics; 2018 Dec; 44(12):830-834. PubMed ID: 30154216
[TBL] [Abstract][Full Text] [Related]
3. The Room Where It Happens: Clinician Reflections on Returning Preclinical Alzheimer's Biomarker Results to Research Participants.
Erickson CM; Chin NA; Ketchum FB; Eveler ML; Conway CE; Coughlin DM; Clark LR
J Prev Alzheimers Dis; 2024; 11(1):1-6. PubMed ID: 38230711
[TBL] [Abstract][Full Text] [Related]
4. Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.
Bemelmans SA; Tromp K; Bunnik EM; Milne RJ; Badger S; Brayne C; Schermer MH; Richard E
Alzheimers Res Ther; 2016 Nov; 8(1):46. PubMed ID: 27832826
[TBL] [Abstract][Full Text] [Related]
5. Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.
Ketchum FB; Chin NA; Grill J; Gleason CE; Erickson C; Clark LR; Paulsen JS; Kind AJH
Alzheimers Dement; 2022 Oct; 18(10):1969-1979. PubMed ID: 35213786
[TBL] [Abstract][Full Text] [Related]
6. Cognitively Healthy Individuals Want to Know Their Risk for Alzheimer's Disease: What Should We Do?
Stites SD
J Alzheimers Dis; 2018; 62(2):499-502. PubMed ID: 29480203
[TBL] [Abstract][Full Text] [Related]
7. Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society.
Erickson CM; Clark LR; Ketchum FB; Chin NA; Gleason CE; Largent EA
Alzheimers Dement (Amst); 2022; 14(1):e12339. PubMed ID: 36035626
[TBL] [Abstract][Full Text] [Related]
8. Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
Ketchum FB; Erickson CM; Basche KE; Chin NA; Rosario HL; Johnson SC; Clark LR
J Alzheimers Dis; 2023; 96(2):515-522. PubMed ID: 37807783
[TBL] [Abstract][Full Text] [Related]
9. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.
Vermunt L; Muniz-Terrera G; Ter Meulen L; Veal C; Blennow K; Campbell A; Carrié I; Delrieu J; Fauria K; Huesa Rodríguez G; Ingala S; Jenkins N; Molinuevo JL; Ousset PJ; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ;
Alzheimers Res Ther; 2020 Jan; 12(1):8. PubMed ID: 31907067
[TBL] [Abstract][Full Text] [Related]
10. Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.
Kim SY; Karlawish J; Berkman BE
Neurology; 2015 Apr; 84(14):1488-94. PubMed ID: 25762713
[TBL] [Abstract][Full Text] [Related]
11. Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment?
Cox CG; Ryan MM; Gillen DL; Grill JD
J Prev Alzheimers Dis; 2021; 8(1):52-58. PubMed ID: 33336225
[TBL] [Abstract][Full Text] [Related]
12. Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results.
Gooblar J; Roe CM; Selsor NJ; Gabel MJ; Morris JC
JAMA Neurol; 2015 Dec; 72(12):1484-90. PubMed ID: 26501506
[TBL] [Abstract][Full Text] [Related]
13. Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease Research.
Milne R; Bunnik E; Tromp K; Bemelmans S; Badger S; Gove D; Maman M; Schermer M; Truyen L; Brayne C; Richard E
J Prev Alzheimers Dis; 2017; 4(2):125-131. PubMed ID: 29186282
[TBL] [Abstract][Full Text] [Related]
14. European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol.
Solomon A; Kivipelto M; Molinuevo JL; Tom B; Ritchie CW;
BMJ Open; 2019 Feb; 8(12):e021017. PubMed ID: 30782589
[TBL] [Abstract][Full Text] [Related]
15. The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0.
Ritchie CW; Muniz-Terrera G; Kivipelto M; Solomon A; Tom B; Molinuevo JL
J Prev Alzheimers Dis; 2020; 7(1):8-13. PubMed ID: 32010920
[TBL] [Abstract][Full Text] [Related]
16. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
Vermunt L; Veal CD; Ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Molinuevo JL; Porteous D; Ritchie K; Scheltens P; Ousset PJ; Ritchie CW; Luscan G; Brookes AJ; Visser PJ
Alzheimers Dement; 2018 Jun; 14(6):837-842. PubMed ID: 29604264
[TBL] [Abstract][Full Text] [Related]
17. Communicating Alzheimer's biomarker results to cognitively unimpaired research participants: Satisfaction, utility, and impact on research attitudes.
Erickson CM; Ketchum FB; Basche KE; Chin NA; Eveler ML; Clark LR
Alzheimers Dement (N Y); 2024; 10(2):e12483. PubMed ID: 38882702
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.
Milne R; Bunnik E; Diaz A; Richard E; Badger S; Gove D; Georges J; Fauria K; Molinuevo JL; Wells K; Ritchie C; Brayne C
J Alzheimers Dis; 2018; 62(2):487-498. PubMed ID: 29480179
[TBL] [Abstract][Full Text] [Related]
19. Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial.
Grill JD; Raman R; Ernstrom K; Wang S; Donohue MC; Aisen PS; Karlawish J; Henley D; Romano G; Novak G; Brashear HR; Sperling RA
Neurol Clin Pract; 2024 Apr; 14(2):e200265. PubMed ID: 38585443
[TBL] [Abstract][Full Text] [Related]
20. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials.
Grill JD; Zhou Y; Elashoff D; Karlawish J
Neurobiol Aging; 2016 Mar; 39():147-53. PubMed ID: 26923411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
